There is an urgent need in society for a simple test, suited for cancer screening. For example, most operations for prostate cancer have been done without due cause, which means completely unnecessary costs. With ProsMedic, that changes completely. With our single-step process, it is estimated that global costs for treatment of prostate cancer can be reduced by half.
Overtreatment is not only costly, it also puts people through unnecessary suffering. Waiting for a diagnosis, regardless of the outcome, is extremely stressful. It is also a fact that the early detection of cancer is the key to successful treatment. With ProsMedic on the market, it will be more feasible to open up for broader screening, and even self-testing at home.
The fact that cancer exosomes leak into the blood from the tumor is the basis for our ground-breaking diagnostic method. ProsMedic’s method is unique and protected by patents.
One blood sample is all we need to detect prostate cancer.
Patients can live 8 years longer on average if cancer is detected earlier through screening and can be treated. And many will be totally cured.
ProsMedic’s solution is the product of over 40 years of dedicated research. The key to the solution came from the discovery of small vesicles in prostate fluid that act like messengers in the body.
About ProsMedic